https://www.selleckchem.com/pr....oducts/dl-ap5-2-apv.
BACKGROUND In a previous study (Goebel et. al, Cancer Genomics Proteomics 16229-244, 2019), we identified 33 biomarkers for an early stage (I-II) Non-Small Cell Lung Cancer (NSCLC) test with 90% accuracy, 80.3% sensitivity, and 95.4% specificity. For the current study, we used a narrowed ensemble of 21 biomarkers while retaining similar accuracy in detecting early stage lung cancer. METHODS A multiplex platform, 486 human plasma samples, and 21 biomarkers were used to develop and validate our algorithm which detects early stage NSC
Like
Comment
Share
